GEN Exclusives

More »

GEN News Highlights

More »
Sep 17, 2009

imaGenes Becomes BioTrove’s OpenArray Service Provider

  • imaGenes will complement its offerings with BioTrove’s OpenArray® platform, a nanoliter real-time qPCR system that allows for about 9,000 assays simultaneously. imaGenes is BioTrove’s first OpenArray service provider for real-time qPCR analysis outside the U.S. “We chose imaGenes for their extensive experience in microarray and next-generation sequencing services,” says Derek Potter, BioTrove’s European director.

    The high-throughput OpenArray platform delivers superior performance to comparative qPCR systems in a much easier to use format, according to the firms. The technology enables gene-expression profiling, miRNA-profiling analyses, and biomarker studies to be completed in days instead of weeks and at a much lower price, they add.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »